Skip to main content

Advertisement

SpringerLink
Log in

Understanding the "lucky few": The conundrum of HIV-exposed, seronegative individuals

  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

It has been known for many years that not all individuals who are repeatedly exposed to HIV-1 show evidence of viral replication, seroconvert, and eventually develop disease. Quite apart from those who seroconvert but progress slowly to AIDS (ie, slow progressors, longterm nonprogressors, elite controllers), these rare, exposed seronegatives either resist infection or harbor extremely low levels of virus that may be detected only using ultrasensitive methods (occult infection). The correlates of protection that confer this unique status to a tiny minority of HIV-exposed individuals remain a subject of intense interest, investigation, and controversy, as no single genetic or immunologic parameter has yet been able to fully explain this phenomenon. However, there is general consensus that studying these individuals may provide invaluable information to aid in the design of vaccines and therapeutic approaches. This review describes the major findings on this important topic, with a focus on immunologic studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Pinto LA, Sullivan J, Berzofsky JA, et al.: ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 1995, 96:867–876.

    PubMed  CAS  Google Scholar 

  2. Clerici M, Levin JM, Kessler HA, et al.: HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 1994, 271:42–46.

    Article  PubMed  CAS  Google Scholar 

  3. Skurnick JH, Palumbo P, De Vico A, et al.: Correlates of non-transmission in United States women at high risk of HIV-1 transmission through sexual exposure. J Infect Dis 2002, 185:428–438.

    Article  PubMed  Google Scholar 

  4. Clerici M, Giorgi JV, Chou CC, et al.: Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992, 165:1012–1019. One of the first reports of HIV-1-specific T-cell immunity in ESN men, this study used an IL-2-dependent cell line to detect IL-2 production by CD4+ T cells.

    PubMed  CAS  Google Scholar 

  5. Goh WC, Markee J, Akridge RE, et al.: Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. J Infect Dis 1999, 179:548–557.

    Article  PubMed  CAS  Google Scholar 

  6. Rowland-Jones SL, Dong T, Fowke KR, et al.: Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998, 102:1758–1765. The first published report to describe HIV-1-specific CTL responses in ESN sex workers from the Pumwani cohort in Nairobi, Kenya.

    PubMed  CAS  Google Scholar 

  7. Scott-Algara D, Truong LX, Versmisse P, et al.: Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol 2003, 171:5663–5667.

    PubMed  CAS  Google Scholar 

  8. Truong LX, Luong TT, Scott-Algara D, et al.: CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam. AIDS 2003, 17:1425–1434.

    Article  PubMed  CAS  Google Scholar 

  9. Rowland-Jones SL, Nixon DF, Aldhous MC, et al.: HIVspeci-fic cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993, 341:860–861.

    Article  PubMed  CAS  Google Scholar 

  10. Kelker HC, Seidlin M, Vogler M, Valentine FT: Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens. AIDS Res Hum Retroviruses 1992, 8:1355–1359.

    PubMed  CAS  Google Scholar 

  11. Rowland-Jones S, Sutton J, Ariyoshi K, et al.: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995, 1:59–64. One of the first reports of HIV-1-specific CTL in ESN cohorts, this paper describes a cohort of ESN women in the Gambia.

    Article  PubMed  Google Scholar 

  12. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E: Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest 1994, 93:1293–1297.

    PubMed  CAS  Google Scholar 

  13. Bernard NF, Yannakis CM, Lee JS, Tsoukas CM: Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons. J Infect Dis 1999, 179:538–547.

    Article  PubMed  CAS  Google Scholar 

  14. Kaul R, Plummer FA, Kimani J, et al.: HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 2000, 164:1602–1611.

    PubMed  CAS  Google Scholar 

  15. Kaul R, Rowland-Jones SL, Kimani J, et al.: Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J Clin Invest 2001, 107:341–349. This paper describes seroconversion in ESN CSW following a "break" in sex work, suggesting that continuous exposure is importance for maintenance of protective immune responses.

    PubMed  CAS  Google Scholar 

  16. Kaul R, Dong T, Plummer FA, et al.: CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest 2001, 107:1303–1310.

    Article  PubMed  CAS  Google Scholar 

  17. Hladik F, Desbien A, Lang J, et al.: Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells. J Immunol 2003, 171:2671–2683. This careful study evaluates T-cell responses in a longitudinal study of ESN men from the Seattle area.

    PubMed  CAS  Google Scholar 

  18. Wassef NM, Young J, Miller R: Viral reservoirs/transient infection in HIV/AIDS: where are we now and where should we go? Summary of the June 13–14, 2002 Think Tank meeting. AIDS Res Hum Retroviruses 2003, 19:333–344.

    Article  PubMed  Google Scholar 

  19. Yang OO, Boscardin WJ, Matud J, et al.: Immunologic profile of highly exposed yet HIV type 1-seronegative men. AIDS Res Hum Retroviruses 2002, 18:1051–1065.

    Article  PubMed  CAS  Google Scholar 

  20. Clerici M, Clark EA, Polacino P, et al.: T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 1994, 8:1391–1395.

    Article  PubMed  CAS  Google Scholar 

  21. Jennes W, Vuylsteke B, Borget MY, et al.: HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d‘Ivoire. J Infect Dis 2004, 189:602–610.

    Article  PubMed  Google Scholar 

  22. Mazzoli S, Lopalco L, Salvi A, et al.: Human immunode-ficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons. J Infect Dis 1999, 180:871–875.

    Article  PubMed  CAS  Google Scholar 

  23. Kaul R, Trabattoni D, Bwayo JJ, et al.: HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999, 13:23–29.

    Article  PubMed  CAS  Google Scholar 

  24. Beyrer C, Artenstein AW, Rugpao S, et al.: Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. J Infect Dis 1999, 179:59–67.

    Article  PubMed  CAS  Google Scholar 

  25. Mazzoli S, Trabattoni D, Lo Caputo S, et al.: HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997, 3:1250–1257.

    Article  PubMed  CAS  Google Scholar 

  26. Devito C, Hinkula J, Kaul R, et al.: Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 2000, 14:1917–1920.

    Article  PubMed  CAS  Google Scholar 

  27. Devito C, Broliden K, Kaul R, et al.: Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol 2000, 165:5170–5176.

    PubMed  CAS  Google Scholar 

  28. Dorrell L, Hessell AJ, Wang M, et al.: Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. AIDS 2000, 14:1117–1122.

    Article  PubMed  CAS  Google Scholar 

  29. Jackson S, Prince S, Kulhavy R, Mestecky J: False positivity of enzyme-linked immunosorbent assay for measurement of secretory IgA antibodies directed at HIV type 1 antigens. AIDS Res Hum Retroviruses 2000, 16:595–602.

    Article  PubMed  CAS  Google Scholar 

  30. Wright PF, Kozlowski PA, Rybczyk GK, et al.: Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res Hum Retroviruses 2002, 18:1291–1300.

    Article  PubMed  CAS  Google Scholar 

  31. Koning FA, Jansen CA, Dekker J, et al.: Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behavior. AIDS 2004, 18:1117–1126.

    Article  PubMed  Google Scholar 

  32. Stranford SA, Skurnick J, Louria D, et al.: Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proc Natl Acad Sci U S A 1999, 96:1030–1035.

    Article  PubMed  CAS  Google Scholar 

  33. Ahmed RK, Nilsson C, Biberfeld G, Thorstensson R: Role of CD8+ cell-produced anti-viral factors in protective immunity in HIV-2-exposed but seronegative macaques resistant to intrarectal SIVsm challenge. Scand J Immunol 2001, 53:245–253.

    Article  PubMed  CAS  Google Scholar 

  34. Jennes W, Sawadogo S, Koblavi-Deme S, et al.: Cellular human immunodeficiency virus (HIV)-protective factors: a comparison of HIV-exposed seronegative female sex workers and female blood donors in Abidjan, Cote d‘Ivoire. J Infect Dis 2003, 187:206–214.

    Article  PubMed  Google Scholar 

  35. Fowke KR, Dong T, Rowland-Jones SL, et al.: HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. AIDS Res Hum Retroviruses 1998, 14:1521–1530.

    PubMed  CAS  Google Scholar 

  36. Lopalco L, Barassi C, Pastori C, et al.: CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro. J Immunol 2000, 164:3426–3433.

    PubMed  CAS  Google Scholar 

  37. Lopalco L, Magnani Z, Confetti C, et al.: Anti-CD4 antibodies in exposed seronegative adults and in newborns of HIV type 1-seropositive mothers: a follow-up study. AIDS Res Hum Retroviruses 1999, 15:1079–1085.

    Article  PubMed  CAS  Google Scholar 

  38. McChesney MB, Collins JR, Lu D, et al.: Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 1998, 72:10029–10035. This study describes an animal model for ESN: seronegative transient viremia in rhesus macaques intravaginally exposed to SIV.

    PubMed  CAS  Google Scholar 

  39. Zhu T, Corey L, Hwangbo Y, et al.: Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J Virol 2003, 77:6108–6116. The first published report of occult infection in ESN individuals using highly sensitive polymerase chain reaction methods.

    Article  PubMed  CAS  Google Scholar 

  40. Koning FA, van der Vorst TJ, Schuitemaker H: Low levels of human immunodeficiency virus type 1 DNA in high-risk seronegative men. J Virol 2005, 79:6551–6553.

    Article  PubMed  CAS  Google Scholar 

  41. Kaslow RA, Dorak T, Tang JJ: Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis 2005, 191(Suppl 1):S68–77. A thorough review of the literature on host genetic variation, including HLA polymorphisms, HIV coreceptors, and other factors, as related to HIV susceptibility.

    Article  PubMed  Google Scholar 

  42. Lockett SF, Robertson JR, Brettle RP, et al.: Mismatched human leukocyte antigen alleles protect against heterosexual HIV transmission. J Acquir Immune Defic Syndr 2001, 27:277–280.

    PubMed  CAS  Google Scholar 

  43. MacDonald KS, Embree J, Njenga S, et al.: Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998, 177:551–556.

    Article  PubMed  CAS  Google Scholar 

  44. Liu R, Paxton WA, Choe S, et al.: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86:367–377.

    Article  PubMed  CAS  Google Scholar 

  45. Liu H, Hwangbo Y, Holte S, et al.: Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. J Infect Dis 2004, 190:1055–1058.

    Article  PubMed  CAS  Google Scholar 

  46. Speelmon E, Livingston-Rosanoff D, Wick D, et al.: Cellular resistance to HIV-1 infection may explain continued seronegativity in select highly exposed individuals [abstract 317]. Proceedings of the 12th Conference on Retroviruses and Opportunistic Infections; Boston: Foundation for Retrovirology and Human Health; 2005.

    Google Scholar 

  47. Zheng YH, Peterlin BM: Intracellular immunity to HIV-1: newly defined retroviral battles inside infected cells. Retrovirology 2005, 2:25.

    Article  PubMed  Google Scholar 

  48. Herr W, Protzer U, Lohse AW, et al.: Quantification of CD8+ T lymphocytes responsive to human immunode-ficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure. J Infect Dis 1998, 178:260–265.

    PubMed  CAS  Google Scholar 

  49. Putkonen P, Makitalo B, Bottiger D, et al.: Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission. J Virol 1997, 71:4981–4984.

    PubMed  CAS  Google Scholar 

  50. Kaul R, Plummer F, Clerici M, et al.: Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection. AIDS 2001, 15:431–432.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, 1 Shields Avenue, 95616, Davis, CA, USA

    Barbara L. Shacklett PhD

Authors
  1. Barbara L. Shacklett PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara L. Shacklett PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shacklett, B.L. Understanding the "lucky few": The conundrum of HIV-exposed, seronegative individuals. Curr HIV/AIDS Rep 3, 26–31 (2006). https://doi.org/10.1007/s11904-006-0005-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-006-0005-2

Keywords

Search

Navigation